NOTES PAYABLE (Details Textual) (USD $)	1 Months Ended		6 Months Ended		15 Months Ended				0 Months Ended	3 Months Ended	6 Months Ended
	Dec. 31, 2011	Oct. 30, 2009	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Dec. 29, 2011	Nov. 01, 2011	Oct. 27, 2011	Mar. 08, 2010 Icon Clinical Research [Member]	Jun. 30, 2012 Icon Clinical Research [Member]	Jun. 30, 2012 Icon Clinical Research [Member]	Mar. 31, 2011 Icon Clinical Research [Member]	Mar. 31, 2011 Icon Clinical Research [Member] Before Amendment [Member]	Mar. 31, 2011 Icon Clinical Research [Member] After Amendment [Member]	Mar. 08, 2010 Convertible Notes Payable [Member]
Business Acquisition, Cost of Acquired Entity, Cash Paid		$ 200,000
Business Acquisition Cost Of Acquired Entity Promissory Note Issued								250,000
Debt Instrument Renegotiated Price							200,000
Debt Instrument, Interest Rate, Stated Percentage			5.00%		5.00%				5.00%	5.00%	5.00%		5.00%	8.00%
Percentage Of Cash Proceeds From Operation To Repay Interest On Convertible Debt	50.00%
Debt Instrument, Convertible, Conversion Price														$ 562.50	$ 1,125
Long-term Debt, Gross	16,883,000		17,302,000		17,302,000	16,876,000
Accounts Payable									1,275,188
Payments of short-term loans			200,000	0	200,000				275,188
Debt Instrument, Periodic Payment, Principal											27,778
One Time Settlement Amount For Waiver Of Interest												100,000
Interest and Debt Expense										15,150	30,003
Notes payable, current portion	877,778		677,778		677,778									677,778
Interest payable, current portion	$ 61,941		$ 91,944		$ 91,944
Debt Instrument Repayment Term										36 months	36 months
Waiver Period Interest											13 months